Axsome TherapeuticsAXSM
About: Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
Employees: 589
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
77% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 26
8% more funds holding
Funds holding: 254 [Q2] → 274 (+20) [Q3]
4% more capital invested
Capital invested by funds: $3.3B [Q2] → $3.43B (+$132M) [Q3]
2% more call options, than puts
Call options by funds: $95.7M | Put options by funds: $94M
5.95% less ownership
Funds ownership: 86.44% [Q2] → 80.49% (-5.95%) [Q3]
13% less repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 93
27% less funds holding in top 10
Funds holding in top 10: 11 [Q2] → 8 (-3) [Q3]
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
5 analyst ratings
Cantor Fitzgerald Charles Duncan 39% 1-year accuracy 32 / 82 met price target | 39%upside $121 | Overweight Reiterated | 12 Dec 2024 |
HC Wainwright & Co. Raghuram Selvaraju 38% 1-year accuracy 118 / 313 met price target | 107%upside $180 | Buy Reiterated | 27 Nov 2024 |
Baird Joel Beatty 48% 1-year accuracy 21 / 44 met price target | 33%upside $116 | Outperform Maintained | 13 Nov 2024 |
Needham Ami Fadia 32% 1-year accuracy 49 / 154 met price target | 49%upside $130 | Buy Reiterated | 13 Nov 2024 |
RBC Capital Leonid Timashev 43% 1-year accuracy 19 / 44 met price target | 51%upside $131 | Outperform Maintained | 4 Oct 2024 |
Financial journalist opinion
Based on 3 articles about AXSM published over the past 30 days